Andrew Zacher serves as Senior Director, Regulatory & Public Policy at Amneal Pharmaceuticals, where he leads the company’s engagement on key regulatory and legislative issues affecting the pharmaceutical industry. A former FDA senior leader and Congressional advisor, Andrew brings extensive experience in drug regulation, public policy development, and stakeholder engagement. His career has spanned leadership roles at FDA, the U.S. Senate HELP Committee, HHS, and private practice, providing a unique perspective on the intersection of law, regulation, and healthcare policy.